Prostate cancer may increase risk of blood clots
Men with prostate cancer, particularly those receiving hormone therapy, may face an increased risk of blood clots or 'thromboembolism', scientists at King's College London have found.
Cancer is already known to increase the risk of blood clots, but the underlying reasons for this effect are unclear.
Mieke Van Hemelrijck, a PhD student at King's, explained that little is known about the specific association between prostate cancer and blood clots, although previous research had shown men to face an increased likelihood of thromboembolic disease after receiving hormone therapy.
Read the whole article at Cancer Research UK
Reference
- Van Hemelrijck, M. et. al. (2010). Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden The Lancet Oncology, 11 (5), 450-458 DOI: 10.1016/S1470-2045(10)70038-3
Keywords: prostate cancer, blood clots
15. 4. 2010 Cancer Research UK
